[Edaily Reporter Kwon Oh Seok ] Kolon TissueGene, Inc.(950160)announced on the 18th that it is transitioning from a co-CEO system led by Jeon Seung-ho and Noh Moon-jong to a system led solely by CEO Jeon Seung-ho.
Disclosure Plus
Kolon TissueGene, Inc. Transitions to a Management Structure Led by CEO Jeon Seung-ho
Kwon Oh Seok
2026-09-18 18:17:00
Economy
Corporation
IT·Science
Economy
[VC's Pick] The AI That Played a Match Against Lee Sedol 9-dan… Enhance Secures 51.2 Billion Investment
This week (September 14–18), startups in various fields—including medical artificial intelligence (AI), content solutions, and content tech—secured investments from venture capital (VC) firms and acce…
Corporation
Kang Seong-min, CEO of PeopleBio, Inc.: “Full-Scale Launch of LDT and Diagnostic Kit Business in the U.S. … Revenue to Become Apparent Starting Next Year”
“Building on our designation as an innovative medical device by the U.S. Food and Drug Administration (FDA), we plan to establish a local subsidiary within this year. Next year, we will launch laborat…
IT·Science
Opacalim Clinical Trials Paused… A Closer Look at the Preconditions for SK BIOPHARMACEUTICALS’s 2.3 Trillion Won Deal
SK BIOPHARMACEUTICALS(326030)has drawn attention by repeatedly emphasizing that the deal to acquire “Opacalym” (BHV-7000), a new drug candidate for epilepsy, from the U.S. biotech company Biohaven is …
